Interesting MU Put And Call Options For December 2028

Micron (MU) is being presented with two options strategies: a sell-to-open $310 put (current bid $110.50) which nets an effective share cost basis of $199.50 vs. the spot $317.44, with a 75% probability to expire worthless and a YieldBoost of 35.65% (12.10% annualized). The covered-call example sells the $390 call (bid $119.00) against shares at $317.44, offering a 60.35% total return if called by Dec 2028 and a 37.49% premium boost (12.73% annualized) with a 33% chance to expire worthless; implied vols are ~67% (put) and 65% (call) versus trailing 12-month volatility of 62%.

Analysis

Market structure: The options market is signaling elevated but not extreme stress in MU (IV ~66% vs realized 62%), creating attractive risk premia for option sellers. Sellers of the Dec 2028 $310 put collect $110.50 (implied post-assignment basis $199.50) with a ~75% modeled chance to expire worthless, while the Dec 2028 $390 covered-call yields ~60% total to $390 (12.7% annualized) with ~33% chance to expire worthless. This favors disciplined cash‑secured put and covered‑call programs for patient, yield‑seeking traders but rewards active risk management because underlying memory cyclicality can move >30% in quarters.

Risk assessment: Tail risks include a memory demand collapse ( >30% price reset in 3–12 months), major China export curbs cutting Chinese server/storage demand, or sudden capex surges that flood supply and compress ASPs. Immediate (days) risks are IV spikes around earnings; short term (weeks–months) risk drivers are inventory reports and macro PC/phone data; long term (quarters–years) is AI datacenter adoption which could materially raise DRAM wallet share. Hidden dependencies: option greeks assume stable skew/liquidity — a volatility regime shift would widen bid-ask and hurt large sellers; stock borrow/assignment timing can create margin shocks.

Trade implications: Implement cash‑secured Dec 2028 $310 put sales sized to no more than 2–3% portfolio (one contract = $31k notional) to target entry at $199.50 effective basis, and size covered-call overlays (buy MU, sell Dec 2028 $390) for 1–2% portfolio allocations if willing to cap upside at $390. Use asymmetric protection by pairing put sales with cheap long puts (buy Dec 2028 $250) as a defined‑risk vertical or buy 1–2% tail‑hedge (Dec 2024/2025 20–30% OTM puts) around earnings. Rotate 1–3% from high‑multiple AI names into MU if AI server demand evidence (supplier bookings) emerges over next 6–12 months.

Contrarian angles: Consensus treats MU like a pure cyclical with mean reversion; that understates secular AI-driven DRAM upside where supply elasticity is limited by multi‑year capex cycles — if datacenter spending accelerates, MU could re-rate >30% over 12–24 months. Conversely, option sellers may be underpricing multi‑quarter downside; don’t naked‑sell beyond cash‑secured sizes and set stop‑loss/roll rules (close if stock falls >25% or IV rises >50% from baseline). Historical parallel: 2016–2018 memory upcycle showed >2x moves inside 12–18 months, so risk asymmetry is real both ways.

Key Decisions for Investors

• Sell cash‑secured Dec 2028 MU $310 puts (collect $110.50) sized to represent no more than 2–3% of portfolio notional (one contract = $31,000 reserve); target effective basis $199.50 and close/roll if MU falls >25% or implied vol spikes >50% from current.
• Buy MU shares up to 1–2% portfolio and sell Dec 2028 $390 calls (collect $119) as a covered‑call overlay to lock ~12.7% annualized yieldBoost; let be called at $390 or roll if MU > $390 with >15% upside remaining before expiry.
• If risk‑averse, structure a defined‑risk collar: sell Dec 2028 $310 put and buy Dec 2028 $250 put (1:1) to cap downside; limit collar allocations to 1–2% portfolio and reassess after next two quarterly earnings/DRAM spot price prints.
• Rotate 1–3% from high‑multiple AI names (e.g., trim NVDA by 1–3%) into MU over next 3 months if server/AI capex indicators (server billings, Micron bookings) confirm demand; pair overweight MU / underweight NVDA for relative value until mid‑2026.